|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News
|
Erin Kutz |
01/11/12 |
Boston
|
|
Foundation Medicine and Sanofi Form Cancer Discovery Pact
|
Arlene Weintraub |
01/10/12 |
Boston
|
|
Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi
|
Arlene Weintraub |
01/10/12 |
Boston
|
|
IBM Gets Emptoris, Nuance Buys Vlingo, & More Boston-Area Deals News
|
Erin Kutz |
12/21/11 |
Boston
|
|
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers
|
Erin Kutz |
12/16/11 |
Boston
|
|
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics
|
Luke Timmerman |
12/15/11 |
Boston
|
|
Ember Therapeutics Garners $34,000,000 Series A Funding
|
VentureDeal |
12/15/11 |
Boston
|
|
Allena Kicks Off With $15M, Security Firms Ink Funding, TeraDiode Takes In $10M, & More Boston-Area Deals News
|
Erin Kutz |
11/23/11 |
Boston
|
|
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News
|
Erin Kutz |
11/18/11 |
Boston
|
|
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds
|
Arlene Weintraub |
11/17/11 |
Boston
|
|
Allena Pharmaceuticals Receives $15,000,000 Series A Round
|
VentureDeal |
11/17/11 |
Boston
|
|
Agios Pharmaceuticals Obtains $78,000,000 Series C Round
|
VentureDeal |
11/17/11 |
Boston
|
|
Allena Pharma Launches With $15M From Third Rock and Other Top-Tier VCs
|
Arlene Weintraub |
11/16/11 |
Boston
|
|
Rhythm Adds Former Merck VP as CEO
|
Erin Kutz |
11/09/11 |
Boston
|
|
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity
|
Arlene Weintraub |
10/25/11 |
Boston
|
|
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
|
Luke Timmerman |
10/24/11 |
National
|
|
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More
|
Lilly O'Flaherty |
10/21/11 |
Boston
|
|
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/21/11 |
Boston
|
|
Kleiner Perkins, Google Ventures Join Expanded $33.5M Round for Foundation Medicine
|
Luke Timmerman |
10/18/11 |
Boston
|
|
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases
|
Arlene Weintraub |
10/18/11 |
Boston
|
|
SAGE Therapeutics Obtains $35,000,000 Series A Funding
|
VentureDeal |
10/18/11 |
Boston
|
|
TOPICA Pharmaceuticals Receives $27,000,000 Series B Financing
|
VentureDeal |
10/18/11 |
San Francisco
|
|
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos
|
Erin Kutz |
10/13/11 |
Boston
|
|
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage
|
Arlene Weintraub |
10/11/11 |
Boston
|
|
Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership
|
Luke Timmerman |
10/05/11 |
Boston
|
|
Eleven Biotherapeutics Dials Up New CEO, Primes Lead Eye Drug for Clinic Next Year
|
Luke Timmerman |
09/22/11 |
Boston
|
|
Sabet and Wilson Out at Twitter, Hirshland Out at Polaris, & More VC Comings and Goings
|
Gregory T. Huang |
09/22/11 |
Boston
|
|
Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News
|
Erin Kutz |
07/13/11 |
Boston
|
|
The Missing Ingredient in Today’s Biotech: Guts
|
Luke Timmerman |
07/11/11 |
National
|
|
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News
|
Erin Kutz |
07/08/11 |
Boston
|
|
Page 2 of
7 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.